Informação sobre produto
- (11b,16b)-11,21-Dihydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dioneDeacetyldeflazacortDeflazacortalcohol
- (11,16)-11,21-Dihydroxy-2'-methyl-5'H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
- (11β,16β)-11,21-Dihydroxy-2′-methyl-5′H-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
- (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a,8-trimethyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]oxazol-2-one
- 21-Deacetyldeflazacort
- 21-Desacetyldeflazacort
- 5′H-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 11,21-dihydroxy-2′-methyl-, (11β,16β)-
- 5′β<span class="text-smallcaps">H</span>-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 11β,21-dihydroxy-2′-methyl-
- Deacetyldeflazacort
- Deflazacortalcohol
- Ver mais sinónimos
- L 6485
- 5′βH-Pregna-1,4-dieno[17,16-d]oxazole-3,20-dione, 11β,21-dihydroxy-2′-methyl-
Deflazacort is a synthetic glucocorticoid that is used in the treatment of Duchenne and Becker muscular dystrophy. It has been shown to be effective for the management of inflammatory conditions such as asthma, allergies, and other allergic reactions. Deflazacort binds to and activates glucocorticoid receptors in humans. The drug undergoes rapid metabolism with a terminal half-life of about 1 hour. Deflazacort is eliminated by both urinary excretion and hepatic metabolism. This drug has pharmacokinetic properties that are similar to prednisolone, although it has a longer duration of action due to its slow hepatic clearance.
Propriedades químicas
Consulta técnica sobre: 3D-FD21122 21-Desacetyl deflazacort
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.